Logo image of BWIN

BALDWIN INSURANCE GROUP INC/ (BWIN) Stock Fundamental Analysis

NASDAQ:BWIN - Nasdaq - US05589G1022 - Common Stock - Currency: USD

39.18  -1.07 (-2.66%)

After market: 37.82 -1.36 (-3.47%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BWIN. BWIN was compared to 143 industry peers in the Insurance industry. BWIN has a bad profitability rating. Also its financial health evaluation is rather negative. BWIN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BWIN had positive earnings in the past year.
BWIN had a positive operating cash flow in the past year.
BWIN Yearly Net Income VS EBIT VS OCF VS FCFBWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.10%, BWIN is doing worse than 86.52% of the companies in the same industry.
BWIN has a Return On Equity of -6.52%. This is amonst the worse of the industry: BWIN underperforms 83.69% of its industry peers.
With a Return On Invested Capital value of 1.15%, BWIN perfoms like the industry average, outperforming 42.55% of the companies in the same industry.
Industry RankSector Rank
ROA -1.1%
ROE -6.52%
ROIC 1.15%
ROA(3y)-1.62%
ROA(5y)N/A
ROE(3y)-9.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BWIN Yearly ROA, ROE, ROICBWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -5 -10 -15

1.3 Margins

BWIN has a Operating Margin of 2.71%. This is in the lower half of the industry: BWIN underperforms 78.72% of its industry peers.
Looking at the Gross Margin, with a value of 26.46%, BWIN belongs to the top of the industry, outperforming 87.94% of the companies in the same industry.
Industry RankSector Rank
OM 2.71%
PM (TTM) N/A
GM 26.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BWIN Yearly Profit, Operating, Gross MarginsBWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 10 20

2

2. Health

2.1 Basic Checks

BWIN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BWIN has more shares outstanding
Compared to 1 year ago, BWIN has an improved debt to assets ratio.
BWIN Yearly Shares OutstandingBWIN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
BWIN Yearly Total Debt VS Total AssetsBWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B

2.2 Solvency

BWIN has an Altman-Z score of 1.30. This is a bad value and indicates that BWIN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.30, BWIN belongs to the top of the industry, outperforming 80.85% of the companies in the same industry.
The Debt to FCF ratio of BWIN is 19.78, which is on the high side as it means it would take BWIN, 19.78 years of fcf income to pay off all of its debts.
BWIN has a Debt to FCF ratio of 19.78. This is in the lower half of the industry: BWIN underperforms 72.34% of its industry peers.
A Debt/Equity ratio of 2.35 is on the high side and indicates that BWIN has dependencies on debt financing.
BWIN has a worse Debt to Equity ratio (2.35) than 94.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.35
Debt/FCF 19.78
Altman-Z 1.3
ROIC/WACC0.13
WACC8.51%
BWIN Yearly LT Debt VS Equity VS FCFBWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

BWIN has a Current Ratio of 0.98. This is a bad value and indicates that BWIN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BWIN (0.98) is better than 77.31% of its industry peers.
BWIN has a Quick Ratio of 0.98. This is a bad value and indicates that BWIN is not financially healthy enough and could expect problems in meeting its short term obligations.
BWIN has a Quick ratio of 0.98. This is in the better half of the industry: BWIN outperforms 77.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
BWIN Yearly Current Assets VS Current LiabilitesBWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.55% over the past year.
Measured over the past years, BWIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.53% on average per year.
The Revenue has grown by 24.25% in the past year. This is a very strong growth!
EPS 1Y (TTM)24.55%
EPS 3Y34.53%
EPS 5YN/A
EPS Q2Q%13.79%
Revenue 1Y (TTM)24.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.67%

3.2 Future

Based on estimates for the next years, BWIN will show a very strong growth in Earnings Per Share. The EPS will grow by 29.44% on average per year.
The Revenue is expected to grow by 13.82% on average over the next years. This is quite good.
EPS Next Y34.61%
EPS Next 2Y31.45%
EPS Next 3Y29.44%
EPS Next 5YN/A
Revenue Next Year13.88%
Revenue Next 2Y13.5%
Revenue Next 3Y13.82%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
BWIN Yearly Revenue VS EstimatesBWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
BWIN Yearly EPS VS EstimatesBWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.60 indicates a quite expensive valuation of BWIN.
Compared to the rest of the industry, the Price/Earnings ratio of BWIN indicates a slightly more expensive valuation: BWIN is more expensive than 78.01% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BWIN to the average of the S&P500 Index (29.63), we can say BWIN is valued inline with the index average.
The Price/Forward Earnings ratio is 20.24, which indicates a rather expensive current valuation of BWIN.
BWIN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BWIN is more expensive than 68.09% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. BWIN is around the same levels.
Industry RankSector Rank
PE 28.6
Fwd PE 20.24
BWIN Price Earnings VS Forward Price EarningsBWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BWIN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BWIN is more expensive than 62.41% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BWIN is valued a bit more expensive than the industry average as 73.76% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 64.73
EV/EBITDA 41.96
BWIN Per share dataBWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWIN's earnings are expected to grow with 29.44% in the coming years.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y31.45%
EPS Next 3Y29.44%

0

5. Dividend

5.1 Amount

BWIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BALDWIN INSURANCE GROUP INC/

NASDAQ:BWIN (2/21/2025, 8:04:43 PM)

After market: 37.82 -1.36 (-3.47%)

39.18

-1.07 (-2.66%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-25 2025-02-25/amc
Inst Owners99.47%
Inst Owner ChangeN/A
Ins Owners1.31%
Ins Owner Change-1.14%
Market Cap4.61B
Analysts80
Price Target50.66 (29.3%)
Short Float %6.47%
Short Ratio7.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.98%
Min EPS beat(2)-5.25%
Max EPS beat(2)1.28%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-5.25%
Max EPS beat(4)20.87%
EPS beat(8)5
Avg EPS beat(8)2.83%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)5.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.4%
Min Revenue beat(2)-4.36%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-4.36%
Max Revenue beat(4)-0.45%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.07%
PT rev (3m)-8.02%
EPS NQ rev (1m)-8.03%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-1.24%
EPS NY rev (3m)-1.53%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 28.6
Fwd PE 20.24
P/S 3.43
P/FCF 64.73
P/OCF 42.83
P/B 7.74
P/tB N/A
EV/EBITDA 41.96
EPS(TTM)1.37
EY3.5%
EPS(NY)1.94
Fwd EY4.94%
FCF(TTM)0.61
FCFY1.54%
OCF(TTM)0.91
OCFY2.33%
SpS11.43
BVpS5.06
TBVpS-15.19
PEG (NY)0.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -6.52%
ROCE 1.45%
ROIC 1.15%
ROICexc 1.24%
ROICexgc N/A
OM 2.71%
PM (TTM) N/A
GM 26.46%
FCFM 5.3%
ROA(3y)-1.62%
ROA(5y)N/A
ROE(3y)-9.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 2.35
Debt/FCF 19.78
Debt/EBITDA 9.85
Cap/Depr 34.45%
Cap/Sales 2.71%
Interest Coverage 0.36
Cash Conversion 75.74%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.3
F-Score4
WACC8.51%
ROIC/WACC0.13
Cap/Depr(3y)23.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.55%
EPS 3Y34.53%
EPS 5YN/A
EPS Q2Q%13.79%
EPS Next Y34.61%
EPS Next 2Y31.45%
EPS Next 3Y29.44%
EPS Next 5YN/A
Revenue 1Y (TTM)24.25%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.67%
Revenue Next Year13.88%
Revenue Next 2Y13.5%
Revenue Next 3Y13.82%
Revenue Next 5YN/A
EBIT growth 1Y-47.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year484.37%
EBIT Next 3Y100.58%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1913.32%
OCF growth 3YN/A
OCF growth 5YN/A